Prostate cancer seriously affects the health and life safety of men. PSA is currently
recognized as a biomarker for the diagnosis of prostate cancer, which promotes the
early diagnosis of prostate cancer. But still need to study other biomarkers to find
more effective biomarkers. As an expert in the field of biomarkers, Creative BioMart
Biomarker has rich experience in detecting various tumor-related biomarkers, and
can provide customers with fast and accurate test results.
Prostate Cancer and Biomarker
Prostate cancer is a common male tumor in the world, which brings huge hidden
danger to men’s health. Prostate cancer has a high incidence and it has the
possibility of metastasis. Prostate cancer patients have a high five-year survival rate,
but when the tumor metastasizes, their five-year survival rate decreases significantly.
Prostate cancer also has disease heterogeneity, treatment diversity and disease
behavior variability, so for the treatment of prostate cancer, attention should also be
paid to personalized medical research. And biomarkers have a special status and
development prospects in personalized medicine, which is a research hotspot in
personalized medicine. Biomarkers have already had a great impact on the
diagnosis of prostate cancer. PSA is a recognized biomarker for prostate cancer and
is widely used for the early detection of prostate cancer. Since the use of PSA in the
Services
Prostate Cancer Biomarker Detection
Service
Home Services Single Biomarker Detection Service Oncology Biomarker Detection Service
Prostate Cancer Biomarker Detection Service
Prostate Cancer Biomarker Detection
Service
Inquiry
Biomarker
Discovery and
Analysis
Single Biomarker
Detection Service
Multiple Biomarker
Detection Service
Imaging Biomarker
Detection Service
Custom Biomarker
Service
Application and
Transformation
Service
Services
APP & TECH
Biomarker Menu
Order
Company
diagnosis of prostate cancer, the incidence of prostate cancer has increased, but
the mortality rate has decreas